Constellation Pharmaceuticals Secures $32,000,000 Series A Funding

  • Feed Type
  • Date
    4/29/2008
  • Company Name
    Constellation Pharmaceuticals
  • Mailing Address
    148 Sidney Street Cambridge, MA 02139
  • Company Description
    Constellation Pharmaceuticals is the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression.
  • Website
    '>http://www.constellationpharma.com/
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $32,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds from the financing will be used to establish the discovery platform and accelerate the development of a preclinical candidate pipeline of epigenetic-targeted drugs.
  • M&A Terms
  • Venture Investor
    Third Rock Ventures
  • Venture Investor
    Third Rock Ventures
  • Venture Investor
    Venrock

By posting a comment, you agree to our terms and conditions.